BioNTech's Pioneering $150M Vaccine Hub in Rwanda Marks a Milestone in Global Healthcare
BioNTech, the German biotech giant, has officially launched its state-of-the-art vaccine manufacturing facility in Kigali, Rwanda. The $150 million project, fully funded by BioNTech, has materialized a year after the laying of its foundation.
